-
6Public Stem Cell Banks: Considerations of Justice in Stem Cell Research and TherapyHastings Center Report 33 (6): 13-27. 2012.If stem cells fulfill their therapeutic promise, moving them from the laboratory into the clinic will raise several concerns about justice. One concern is that, for biological reasons alone, stem cell‐based therapies might not be available for every patient who needs one. Worse, depending on how we address the problem of biological access, they might benefit primarily white Americans. We can avoid this outcome—although at a cost—by carefully selecting the stem cells we make available.
-
204Public Stem Cell Banks: Considerations of Justice in Stem Cell Research and TherapyHastings Center Report 33 (6): 13-27. 2003.If stem cell-based therapies are developed, we will likely confront a difficult problem of justice: for biological reasons alone, the new therapies might benefit only a limited range of patients. In fact, they might benefit primarily white Americans, thereby exacerbating long-standing differences in health and health care.
-
61Embryonic stem cell production through therapeutic cloning has fewer ethical problems than stem cell harvest from surplus IVF embryosJournal of Medical Ethics 28 (2): 86-88. 2002.Restrictions on research on therapeutic cloning are questionable as they inhibit the development of a technique which holds promise for succesful application of pluripotent stem cells in clinical treatment of severe diseases. It is argued in this article that the ethical concerns are less problematic using therapeutic cloning compared with using fertilised eggs as the source for stem cells. The moral status of an enucleated egg cell transplanted with a somatic cell nucleus is found to be more cl…Read more
-
86Reflective Inquity and the Nature of Professional GrowthInquiry: Critical Thinking Across the Disciplines 18 (2): 87-94. 1998.
-
77Embryonic stem cell production through therapeutic cloning has fewer ethical problems than stem cell harvest from surplus IVF embryosJournal of Medical Ethics 28 (2): 86-88. 2002.
-
216Embryonic stem cell production through therapeutic cloning has fewer ethical problems than stem cell harvest from surplus IVF embryosJournal of Medical Ethics 28 (2): 86-88. 2002.Restrictions on research on therapeutic cloning are questionable as they inhibit the development of a technique which holds promise for succesful application of pluripotent stem cells in clinical treatment of severe diseases. It is argued in this article that the ethical concerns are less problematic using therapeutic cloning compared with using fertilised eggs as the source for stem cells. The moral status of an enucleated egg cell transplanted with a somatic cell nucleus is found to be more cl…Read more
Waltham, Massachusetts, United States of America
Areas of Interest
| Applied Ethics |
| Philosophy of Cognitive Science |